A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
NCT06362252
This study is recruiting at 24 US sites in 14 states, according to its ClinicalTrials.gov record last updated .
Summary
This study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung cancer (ES-SCLC) in the first-line (1L) setting.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Extensive Stage-small Cell Lung Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Daiichi Sankyo
- Last updated on ClinicalTrials.gov
- October 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama -Birmingham · Birmingham, AL
Arizona · 1
- Mayo Clinic Arizona · Phoenix, AZ
California · 1
- Hoag Memorial Hospital Presbyterian · Newport Beach, CA
Florida · 3
- Mayo Clinic-Jacksonville · Jacksonville, FL
- Advent Health Orlando · Orlando, FL
- Moffitt Cancer Center · Tampa, FL
Illinois · 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Chicago, IL
Minnesota · 2
- Regents of the University of Minnesota · Minneapolis, MN
- Mayo Clinic · Rochester, MN
New Hampshire · 1
- Dartmouth-Hitchcock Medical Center · Lebanon, NH
New Jersey · 2
- Astera Cancer Care · East Brunswick, NJ
- John Theurer Cancer Center At Hackensack Umc · Hackensack, NJ
New York · 5
- New York University Cancer Center - Laura and Isaac Perlmutter Cancer Center At Nyu Langone · Mineola, NY
- NYU Langone Hospital - Long Island · Mineola, NY
- Columbia University Hervert Irving Comprehensive Cancer Center · New York, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- Montefiore Medical Center · New York, NY
Pennsylvania · 3
- Lancaster General Hospital - Ann B Barshinger Cancer Institute · Lancaster, PA
- Thomas Jefferson University Hospital - Central · Philadelphia, PA
- University of Pennsylvania, Abramson Cancer Center · Philadelphia, PA
Tennessee · 1
- Scri Oncology Partners · Nashville, TN
Virginia · 1
- Next Virginia · Fairfax, VA
Washington · 1
- Northwest Cancer Specialists, P.C.-Vancouver · Vancouver, WA
Wisconsin · 1
- Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.